Boehringer Ingelheim’s Strategic Move in Pet Health
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
- Latest
- Trending
Boehringer Ingelheim acquires Saiba Animal Health, boosting pet R&D with innovative therapeutic vaccines.
Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Miami-based HealthSnap raises $25M in Series B funding for its remote patient monitoring and chronic care management solution. The company ...
Virtual Reality is revolutionizing patient care in the medical field by improving surgical outcomes, enhancing patient consultations, and offering novel ...
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.